Joji Joseph

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

Gerhardt Attard, Laura Murphy, Noel W. Clarke et al. · The Lancet Oncology · 2023 · 85 citations · Full text

The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer

D. Ash, Bashar Al‐Qaisieh, David Bottomley et al. · Radiotherapy and Oncology · 2006 · 76 citations

Urology, Genitourinary Cancer, Medicine +7

Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds

David Bottomley, D. Ash, Bashar Al‐Qaisieh et al. · Radiotherapy and Oncology · 2006 · 62 citations

Urology, Side Effects, Benign Prostatic Hyperplasia +2

The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer

D. Ash, Bashar Al‐Qaisieh, David Bottomley et al. · Radiotherapy and Oncology · 2005 · 48 citations

Urology, Iodine-125 Implant Monotherapy, Post-implant Dosimetry +7

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 43 citations · Full text